SuperworthHumacyte shares outstanding HUMA
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Jun 30, 2026
- 234.2M
- On a year earlier
- +50.7%
- more shares
Humacyte had 234.2M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 50.7% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 186.8M | +47% |
| FY2024 | 127M | +23% |
| FY2023 | 103.6M | +0% |
| FY2022 | 103.2M | +0% |
| FY2021 | 103M | +1677% |
| FY2020 | 5.8M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 234.2M | +51% | |
| Q1 FY26 | 197.8M | +50% | |
| Q4 FY25 | 186.8M | +47% | |
| Q3 FY25 | 158.3M | +33% | |
| Q2 FY25 | 155.4M | +30% | |
| Q1 FY25 | 131.8M | +22% | |
| Q4 FY24 | 127M | +23% | |
| Q3 FY24 | 119.4M | +15% | |
| Q2 FY24 | 119.2M | +15% | |
| Q1 FY24 | 108.2M | +5% | |
| Q4 FY23 | 103.6M | +0% | |
| Q3 FY23 | 103.4M | +0% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Humacyte
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.